Literature DB >> 33738033

[Vancomycin-based Lowenstein-Jensen selective medium for reducing contamination of mycobacterial cultures by spore-forming bacteria].

Michel Kiréopori Gomgnimbou1, Babacar Faye2, Juliette Tranchot-Diallo3, Antoinette Kaboré1, Louis Robert Belem1, Dezémon Zingué4, Adama Sanou1, Hervé Hien4, Lassana Sangaré5.   

Abstract

INTRODUCTION: despite the development of new methods, culture on solid medium is the gold standard for the diagnosis of tuberculosis. However, this method is associated with increased rates of contamination of cultures by spore-forming bacteria. These bacteria are generally sensitive to vancomycin and to a combinsation of vancomycin, colistin, nystatin, and trimethoprim (VCNT). The purpose of this study was to assess the effectiveness of VCNT-based selective Lowenstein-Jensen (LJ) medium in reducing contamination of cultures by spore-forming bacteria.
METHODS: sputum samples, collected from the 120 TB and non-TB patients included in the study between October 2016 and May 2017, were decontaminated with the modified Petroff method. Decontamination pellets were inoculated onto conventional LJ media and selective VCNT-based LJ medium containing 10µg/ml vancomycin. Fifteen strains of spore-forming bacteria were inoculated onto the same media in order to assess their sensitivity to VCNT.
RESULTS: the contamination of cultures on VCNT-based LJ medium containing 10µg/ml of vancomycin and LJ medium were 11.66% (14/120) and 39.16% (47/120) with p <0.0001, respectively. Sensitivity of spore-forming bacteria to VCNT decreased with the increasing of culture incubation time.
CONCLUSION: VCNT-based selective LJ medium containing 10µg/ml vancomycin led to a significant reduction in the rate of culture contamination. This environment could contribute to improve the quality of mycobacterial cultures and thus bacteriological diagnosis of tuberculosis. Copyright: Michel Kiréopori Gomgnimbou et al.

Entities:  

Keywords:  Lowenstein-Jensen; Mycobacterium tuberculosis complex; colistin; contamination; nystatin; trimethoprim; vancomycin

Mesh:

Substances:

Year:  2020        PMID: 33738033      PMCID: PMC7934190          DOI: 10.11604/pamj.2020.37.345.23016

Source DB:  PubMed          Journal:  Pan Afr Med J


  13 in total

1.  Use of vancomycin in the culture of Mycobacterium tuberculosis from gastric lavage.

Authors:  S Mathew; C N Paramasivan
Journal:  Indian J Med Res       Date:  2001-04       Impact factor: 2.375

2.  Reduction of contamination of mycobacterial growth indicator tubes with a modified antimicrobial combination.

Authors:  Chulhun Ludgerus Chang; Tae Sung Park; Seung Hwan Oh; Hyung Hoi Kim; Eun Yup Lee; Han Chul Son; Cheol Min Kim
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Impact of mouth rinsing before sputum collection on culture contamination.

Authors:  G Muzanye; K Morgan; J Johnson; H Mayanja-Kizza
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

4.  Moisture transfer from stopper to product and resulting stability implications.

Authors:  M J Pikal; S Shah
Journal:  Dev Biol Stand       Date:  1992

Review 5.  [The new tools of microbiological diagnosis of tuberculosis].

Authors:  C Guillet-Caruba; V Martinez; F Doucet-Populaire
Journal:  Rev Med Interne       Date:  2014-08-08       Impact factor: 0.728

6.  Evaluation of a rapid culture method on liquid Bio FM (BIO-RAD) medium for the isolation of mycobacteria.

Authors:  H Ramarokoto; T Rasolonavalona; L Ratsimba; D Andrianasolo; M Ratsitorahina; V Rasolofo Razanamparany
Journal:  Int J Tuberc Lung Dis       Date:  2007-08       Impact factor: 2.373

7.  Stability of vancomycin in an extemporaneously compounded ophthalmic solution.

Authors:  L C Fuhrman; R T Stroman
Journal:  Am J Health Syst Pharm       Date:  1998-07-01       Impact factor: 2.637

8.  Impact of pre-analytical factors on mycobacterium cultures contaminations rates in Burkina Faso, West Africa.

Authors:  Antoinette Kaboré; Hervé Hien; Adama Sanou; Dézémon Zingué; Géraldine Daneau; Zakaria Ganamé; Moumini Nouctara; Mamoudou Ouédraogo; Oumarou Ouédraogo; Félicité Koutou; Michel Gomgnimbou; Nicolas Méda; Dorine Neveu; Sylvain Godreuil; Lassana Sangaré
Journal:  Pan Afr Med J       Date:  2014-12-22

9.  Evaluation of Culture Media for Isolation of Mycobacterium Species from Human Clinical Specimens.

Authors:  Padmavali Palange; Rahul Narang; Venkataramana Kandi
Journal:  Cureus       Date:  2016-08-30

10.  Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda.

Authors:  C D Kelly-Cirino; E Musisi; P Byanyima; S Kaswabuli; A Andama; A Sessolo; I Sanyu; J Zawedde; P S Curry; L Huang
Journal:  J Epidemiol Glob Health       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.